Inventor
BUTLIN ROGER JOHN
GB15 patents
⚠️ This page may combine multiple inventors who share the name “BUTLIN ROGER JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
6 patentsUS7795283B2Sep 14, 2010
Oxadiazole derivative as DGAT inhibitors
ASTRAZENECA AB15 citations81
US7626020B2Dec 1, 2009
Protected forms of N-(3-methoxy-5-methylpiperazin-2-yl)-2-(4-[1,3,4,-oxadiazol-2-yl]phenyl)-pyridine-3-sulphonamide
ASTRAZENECA AB14 citations79
US6878712B1Apr 12, 2005
Amides as inhibitors for pyruvate dehydrogenase
ASTRAZENECA AB8 citations69
US6689909B1Feb 10, 2004
Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
ASTRAZENECA AB3 citations60
US6552225B1Apr 22, 2003
Chemical compounds
ASTRAZENECA AB7 citations60
US7994179B2Aug 9, 2011
Carbamoyl compounds as DGAT1 inhibitors 190
ASTRAZENECA AB5 citations55
ZENECA LTD
3 patentsUS6060475AMay 9, 2000
Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof
ZENECA LTD21 citations92
US5866568AFeb 2, 1999
Heterocyclic compounds
ZENECA LTD23 citations92
US6258817B1Jul 10, 2001
Substituted pyrazin-2-yl-sulphonamide (-3-pyridyl) compounds and uses thereof
ZENECA LTD4 citations62